A Single Layer Between Inside and Outside
The intestinal epithelium is a single cell layer — just one cell thick — that separates the contents of the gut lumen (food, bacteria, toxins) from the sterile interior of the body. This barrier has the remarkable dual task of absorbing nutrients while excluding harmful substances. Its surface area, amplified by villi and microvilli, covers roughly 32 square metres in an adult human — about the size of a studio apartment.
Three Lines of Defence
The gut barrier operates through three integrated mechanisms:
The mucus layer: Goblet cells secrete a gel-like mucus that coats the epithelium. In the colon, this mucus is organised into two layers — a dense inner layer that is largely sterile and a loose outer layer colonised by commensal bacteria. Mucin glycoproteins (particularly MUC2) provide a physical scaffold that keeps bacteria at a safe distance from the epithelial surface. Akkermansia muciniphila, a commensal bacterium, feeds on mucus and paradoxically stimulates its production, maintaining barrier homeostasis.
Tight junctions: Between adjacent epithelial cells, protein complexes — claudins, occludin, zonula occludens (ZO-1, ZO-2, ZO-3) — form tight junctions that seal the paracellular space. These junctions are not static; they are dynamically regulated and can open or tighten in response to signals from the immune system, diet, microbiota metabolites, and stress hormones.
Antimicrobial peptides: Paneth cells in the small intestine secrete defensins, lysozyme, and RegIIIγ — molecules that directly kill bacteria that approach the epithelial surface. In the colon, IgA secreted by plasma cells in the lamina propria neutralises bacterial toxins and prevents bacterial adherence to epithelial cells.
What Disrupts the Barrier
Multiple factors can compromise intestinal permeability: chronic psychological stress (via CRF-mediated mast cell activation), non-steroidal anti-inflammatory drugs (which directly damage epithelial tight junctions), alcohol (which disrupts ZO-1 distribution), dietary emulsifiers (polysorbate 80 and carboxymethylcellulose have been shown to thin the mucus layer in animal models), and bacterial infection or dysbiosis (which can reduce butyrate availability for colonocyte energy).
The "Leaky Gut" Question
"Leaky gut" is not an accepted medical diagnosis, but increased intestinal permeability is a measurable, documented phenomenon. It has been observed in IBD, coeliac disease, type 1 diabetes, non-alcoholic fatty liver disease, and critical illness. The debate centres on whether increased permeability is a cause or consequence of these conditions — or both, in a feed-forward cycle where barrier breakdown permits antigen translocation, which triggers immune activation, which further damages the barrier.
Clinical Measurement
Intestinal permeability can be assessed using the lactulose-mannitol test (measuring urinary excretion of orally ingested sugars) or by measuring serum markers such as zonulin, intestinal fatty-acid binding protein (I-FABP), and lipopolysaccharide-binding protein (LBP). However, none of these markers are standardised for routine clinical use, and reference ranges vary between laboratories.